Quantcast
Last updated on April 18, 2014 at 6:03 EDT

Health Robotics’ i.v.STATION Robot Wins Vodafone Award for Neonatal Care at Mangiagalli’s Policlinic, Milan

July 30, 2012

BOZEN, SUD-TIROL, Italy, July 30, 2012 /PRNewswire/ –

Health Robotics today announced that i.v.STATION and Mangiagalli’s Clinic won a
national grant from the Vodafone Foundation, as selected by Vodafone customers’ votes from
a group of potential projects, all of which were focused on children’s welfare. This grant
provided funding for the i.v.STATION Robot at Mangiagalli, where 6,500 children are born
every year, many of them requiring intensive care and complex medication dilutions
(including multi-ingredient and double dilutions).

Professor Fabio Mosca, Director of the Neonatology and Neonatal Intensive Care Unit at
Ospedale Maggiore Policlinico’s Mangiagalli Institute, stated: “I’m very pleased to have
finally found in i.v.STATION the right technology to handle the complexity of Sterile
Compounding for Neonatal Care. I’m also very proud that this world-class Robot is
implemented in such a challenging environment as Mangiagalli, in synergy with all the
other advanced technologies at our disposal. After extensive due diligence, I’m sure that
i.v.STATION will allow us to close the loop in therapeutics, and offer maximum safety to
our life-critical newborns.”

Health Robotics’ i.v.STATION and i.v.STATION ONCO’s small footprint allow their
installation in direct patient care areas, while their unique features such as complex
drug dilutions in vials, syringes, and I.V. Bags are also behind the success that Health
Robotics has experienced with its 2nd Generation Robots in the past 2+ years, dominating
the world’s I.V. Automation industry over its competitors[1].

Gaspar DeViedma, Health Robotics’ Executive Vice President, stated: “This is yet
another testimonial to the fact that Health Robotics is the only I.V. Automation company
in the world that currently provides complex medication dilutions and multi-ingredient
Sterile Compounding. We warmly welcome Mangiagalli to the growing list of prestigious
hospitals implementing i.v.STATION for Pediatric and Neonatal Care, such as Children’s
Hospital of Los Angeles, Duke University Children’s Hospital, Miller Children’s Hospital,
Sophia Children’s Hospital at Erasmus University Medical Center, and Ankara Numune
Hospital.”

About Mangiagalli’s Institute at Ospedale Maggiore Policlinico, Milan:

The Neonatal Intensive and Special Care Units at Mangiagalli aim to offer specialized
care and treatment to patients from Milan and the Lombardy region. The Department of
Neonatal Medicine has 15 beds in Neonatal Intensive Care, and 38 beds in the Special Care
Unit. As part of the IRCCS Foundation (Istituto di Ricovero e Cura a Carattere
Scientifico), the Ospedale Maggiore Policlinico Mangiagalli and Regina Elena, and the
Neonatology and Neonatal Intensive Care Unit are committed to improve the training
provided to health professionals and increasing scientific research by including
collaborative projects with the University of Milan. For more information, please visit:

http://www.mangiagalli.it

About Health Robotics:

Founded in 2006, Health Robotics is the undisputed global leading supplier of life-
critical intravenous medication robots, winning 100% of all worldwide I.V. Robot’s
publicly announced purchases in 2010 and 2011, and providing over 300 hospital
installations in 5 continents with robotics-based technology and clinical software
automation solutions. Health Robotics’ world-leading solutions CytoCare(R) and
i.v.STATION(R) ONCO [hazardous IVs], i.v.STATION(R) [non-hazardous IVs], i.v.SOFT(R)
[workflow engine for sterile compounding], OMM(R) [Oncology Medication Management],
MEDarchiver(R) [life-critical clinical information system], and TPNstation(R)
[totally-automated parenteral nutrition] have and will greatly contribute to ease
hospitals’ growing pressures to improve patient safety, increase throughput and contain
costs. Through the effective and efficient production of sterile, accurate, tamper-evident
and ready-to-administer IVs, Health Robotics’ products help hospitals eliminate
life-threatening drug and diluent exchange errors, decrease other medical mistakes and
sterility risks, work more efficiently, reduce waste and controlled substances’ diversion,
and diminish the gap between rising patient volume/acuity and scarce medical, nursing, and
pharmacy staff. For more information, please visit: http://www.health-robotics.com

        For additional information, please contact:
        Luisa Celeghin
        info@health-robotics.com
        Phone (Canada): +1-289-470-1456
        Phone (Europe): +39-0403-498-468

1. Competitors: Loccioni, IHS/RIVA, MDS (now Fresenius Kabi), FHT/Baxa (now Baxter)

SOURCE Health Robotics


Source: PR Newswire